- Treatment of diabetes insipidus:
- Adults:
- Initially PO 0.05mg BD. Effective range: 0.1-1.2mg divided BD/TDS
- Nasal: 0.2mL daily in two divided doses
- Adults:
-
- 3 months-4 years:
- Initially PO 0.05mg OD. Effective range: 0.1-0.8mg/day divided BD
- Initially PO 0.05mg OD. Effective range: 0.1-0.8mg/day divided BD
- 3 months-4 years:
-
- >4 years:
- Initially PO 0.05mg BD. Effective range: 0.1-1.2mg/day divided BD/TDS
- Max: 1.2mg/day
- >4 years:
-
- 3 months-12 years:
- Nasal: 0.05 to 0.3 mL daily, either as a single dose or divided into two doses.
- 3 months-12 years:
- Nocturnal enuresis:
- Adults and >6 years:
- PO 0.2mg every night at bedtime.
- Max: 0.6mg/day
- Restrict fluid intake >1h before administration until next morning or >8h after admin
- Adults and >6 years:
- Renal concentration capacity test:
- Adults and >6 years:
- PO 0.6mg x1
- Give after bladder is emptied
- Adults and >6 years:
- Hemophilia A:
- IV 0.3mcg/kg/dose x1 given over 15-30 minutes (for pre-op, 30 min before procedure)
- IV 0.3mcg/kg/dose x1 given over 15-30 minutes (for pre-op, 30 min before procedure)
- Von Willebrand Disease (Type 1):
- IV 0.3mcg/kg/dose x1 given over 15-30 minutes (for pre-op, 30 min before procedure)
Tablet:
- 0.1mg
- 0.2mg
Injection:
- 4mcg/mL
Nasal spray:
- 0.1mg/mL
- Avoid caffeine and alcohol at bedtime
It increases water permeability in renal tubular cells, which in turn decreases urine volume and increases urine osmolality
- Flushing
- Headache
- Rhinitis
- Nausea
- Abdominal pain
- Dizziness
- Cough
- Epistaxis
- Rigors
- Conjunctivitis
- Hypertension
- Hypotension
- Hypersensitivity to class/components
- Patients <3 months (Hemophilia/ Von Willebrand disease)
- CrCl <50
- Von Willebrand disease Type IIb
- Hyponatremia or history
- Intranasal mometasone
Drug Status
Availability | Prescription only |
Pregnancy | Category B; Can be used |
Breastfeeding | Can be used |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
DDVAP | 0.2mg | Tablet | 100’s | Ferring GMBH | Macnaughton Ltd |
DDVAP | 0.1mg | Tablet | 90’s | Ferring GMBH | Macnaughton Ltd |
DDVAP | 4mcg/mL | Injection | 10’s | Ferring GMBH | Macnaughton Ltd |
DDVAP | 0.1mg/mL | Nasal spray | 5mL | Ferring GMBH | Macnaughton Ltd |